Mandate

Vinge advises the founders in connection with Altor’s investment in Audiowell

May 25, 2022 M&A

Vinge advises the founders in connection with Altor Fund V’s investment in the Swedish founded international music group Audiowell. The founders will remain shareholders and continue in their current roles in the development of the group. In connection with the transaction, Audiowell and Altor have partnered up together with the leading music producer Martin Sandberg (a.k.a. Max Martin). Altor and Max Martin will support the founders and the group on its continued growth journey.

The founders - Andreas Romdhane and Josef Svedlund - launched Audiowell with the mission to increase the quality of lifestyle music by dedicating time, resources and partnering up with talented creators. Both founders have worked for more than 20 years as music producers and songwriters, scoring several number-one singles in UK, and working with artists such as Westlife, Kelly Clarkson, Diana Ross and Il Divo to name a few. The group has a music studio complex in Stockholm from where it supports over 100 music creators spanning from the US to Hong Kong and South America, focusing on a broad range of genres such as jazz, relaxation, acoustic, dance, rock and classical.

Vinge’s team consisted mainly of Jonas Johansson, Maria Dahlin Kolvik, Carl Fredrik Wachtmeister and Linnea Petersson (M&A) as well as Viktoria Owetz Leyva and Ellinor Gyllenhammar (VDR Specialists).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025